Education
About Us
Working with TipRanks
Follow Us
Cyclerion Therapeutics,Inc. (CYCN)
:CYCN
CYCN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.27 - $9.47
Previous CloseN/A
Volume28.13K
Average Volume (3M)45.54K
Market Cap
$9.18M
Enterprise Value$6.57M
Total Cash (Recent Filing)$3.64M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding3,210,094
10 Day Avg. Volume74,174
30 Day Avg. Volume45,543
Financial Highlights & Ratios
PEG Ratio-0.58
Price to Book (P/B)0.96
Price to Sales (P/S)0.00
P/FCF Ratio-3.07
Enterprise Value/Market Cap0.72
Enterprise Value/Revenue1.54
Enterprise Value/Gross Profit3.16
Enterprise Value/Ebitda-0.33
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cyclerion Therapeutics News
PremiumCompany Announcements
Cyclerion Therapeutics Gains Shareholder Support at Annual Meeting
PremiumCompany Announcements
Cyclerion Therapeutics Enters $20M Sales Agreement
PremiumMarket News
3 Penny Stocks to Watch Now, 2/4/25
PremiumCompany Announcements
Cyclerion Therapeutics Secures Funding and Expands CNS Focus
Options Prices
Currently, No data available
---
Ownership Overview
21.50% Insiders
1.20% Mutual Funds
8.76% Other Institutional Investors
67.40% Public Companies and
Individual Investors
CYCN FAQ
What was Cyclerion Therapeutics,Inc.’s price range in the past 12 months?
Cyclerion Therapeutics,Inc. lowest stock price was $1.27 and its highest was $9.47 in the past 12 months.
What is Cyclerion Therapeutics,Inc.’s market cap?
Cyclerion Therapeutics,Inc.’s market cap is $9.18M.
When is Cyclerion Therapeutics,Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cyclerion Therapeutics,Inc.’s earnings last quarter?
Currently, no data Available
Is Cyclerion Therapeutics,Inc. overvalued?
According to Wall Street analysts Cyclerion Therapeutics,Inc.’s price is currently Overvalued.
Does Cyclerion Therapeutics,Inc. pay dividends?
Cyclerion Therapeutics,Inc. does not currently pay dividends.
What is Cyclerion Therapeutics,Inc.’s EPS estimate?
Cyclerion Therapeutics,Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyclerion Therapeutics,Inc. have?
Cyclerion Therapeutics,Inc. has 3,210,094 shares outstanding.
What happened to Cyclerion Therapeutics,Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cyclerion Therapeutics,Inc.?
Currently, no hedge funds are holding shares in CYCN
Company Description
Cyclerion Therapeutics,Inc.
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative treatments for serious diseases. The company operates within the biotechnology sector and primarily engages in the research and development of therapeutics aimed at central nervous system (CNS) disorders. Cyclerion leverages its expertise in soluble guanylate cyclase (sGC) stimulators to create novel therapeutics that address high unmet medical needs.
Technical Analysis
Carisma Therapeutics
―
Aprea Therapeutics
―
Evaxion Biotech
―
HCW Biologics
―
Turnstone Biologics Corp.
―